These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 32748331)
1. Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension. Saha S; Chakrabarti S; Singh PK; Poddar J; Satapathi S; Saini S; Kakar SS; Roy P Stem Cell Rev Rep; 2021 Feb; 17(1):132-143. PubMed ID: 32748331 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45 Ratajczak MZ; Bujko K; Ciechanowicz A; Sielatycka K; Cymer M; Marlicz W; Kucia M Stem Cell Rev Rep; 2021 Feb; 17(1):266-277. PubMed ID: 32691370 [TBL] [Abstract][Full Text] [Related]
3. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner. Agrawal H; Das N; Nathani S; Saha S; Saini S; Kakar SS; Roy P Stem Cell Rev Rep; 2021 Feb; 17(1):94-112. PubMed ID: 33029768 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneous expression of ACE2 and TMPRRS2 in mesenchymal stromal cells. Generali M; Kehl D; Wanner D; Okoniewski MJ; Hoerstrup SP; Cinelli P J Cell Mol Med; 2022 Jan; 26(1):228-234. PubMed ID: 34821008 [TBL] [Abstract][Full Text] [Related]
5. Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression. Zlacká J; Stebelová K; Zeman M; Herichová I Physiol Res; 2021 Dec; 70(S2):S177-S194. PubMed ID: 34913351 [TBL] [Abstract][Full Text] [Related]
6. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada. Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740 [TBL] [Abstract][Full Text] [Related]
7. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system. Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662 [TBL] [Abstract][Full Text] [Related]
9. Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia. Bloise E; Zhang J; Nakpu J; Hamada H; Dunk CE; Li S; Imperio GE; Nadeem L; Kibschull M; Lye P; Matthews SG; Lye SJ Am J Obstet Gynecol; 2021 Mar; 224(3):298.e1-298.e8. PubMed ID: 32853537 [TBL] [Abstract][Full Text] [Related]
10. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection. Fuentes-Prior P J Biol Chem; 2021; 296():100135. PubMed ID: 33268377 [TBL] [Abstract][Full Text] [Related]
11. Expression of the SARS-CoV-2 Receptor ACE2 and Protease TMPRSS2 in Ocular Hypertension Eyes of Nonhuman Primate and Human. Sun D; Zhan Z; Wang B; Liu T; Yu M; Lan Y; Li J Curr Eye Res; 2024 Mar; 49(3):270-279. PubMed ID: 38212998 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19. Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500 [TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters. Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438 [TBL] [Abstract][Full Text] [Related]
14. A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice. Wang Y; Takeshita H; Yamamoto K; Huang Y; Wang C; Nakajima T; Nozato Y; Fujimoto T; Yokoyama S; Hongyo K; Nakagami F; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Rakugi H FASEB J; 2021 Mar; 35(3):e21419. PubMed ID: 33566370 [TBL] [Abstract][Full Text] [Related]
15. Human Hematopoietic Stem, Progenitor, and Immune Cells Respond Ex Vivo to SARS-CoV-2 Spike Protein. Ropa J; Cooper S; Capitano ML; Van't Hof W; Broxmeyer HE Stem Cell Rev Rep; 2021 Feb; 17(1):253-265. PubMed ID: 33089452 [TBL] [Abstract][Full Text] [Related]
16. Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review. Li J; Wang Y; Liu Y; Zhang Z; Zhai Y; Dai Y; Wu Z; Nie X; Du L Eur J Med Res; 2022 Feb; 27(1):26. PubMed ID: 35193695 [TBL] [Abstract][Full Text] [Related]
17. ACE2: from protection of liver disease to propagation of COVID-19. Warner FJ; Rajapaksha H; Shackel N; Herath CB Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956 [TBL] [Abstract][Full Text] [Related]
18. Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections. Sato T; Ueha R; Goto T; Yamauchi A; Kondo K; Yamasoba T Laryngoscope; 2021 Mar; 131(3):E932-E939. PubMed ID: 32940922 [TBL] [Abstract][Full Text] [Related]
19. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2. Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758 [TBL] [Abstract][Full Text] [Related]
20. A low aldosterone/renin ratio and high soluble ACE2 associate with COVID-19 severity. Akin S; Schriek P; van Nieuwkoop C; Neuman RI; Meynaar I; van Helden EJ; Bouazzaoui HE; Baak R; Veuger M; Mairuhu RATA; van den Berg L; van Driel V; Visser LE; de Jonge E; Garrelds IM; Duynstee JFAB; van Rooden JK; Ludikhuize J; Verdonk K; Caliskan K; Jansen T; van Schaik RHN; Danser AHJ J Hypertens; 2022 Mar; 40(3):606-614. PubMed ID: 34862332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]